ClinicalTrials.gg
Not yet recruitingNCT07899983Updated Oct 28, 2026

Effect of Povidone Iodine on the Dental Implant Internal Surface Microbiome

A Phase 1/2 interventional study of Povidone-Iodine in Dental Implant, sponsored by Madigan Army Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Madigan Army Medical Center · Phase 1/2, Interventional, and Prevention

Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Phase 1/2
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

We hope to learn if applying antiseptic to the inside of a dental implant will decrease or alter the types of bacteria inside it which may then decrease the incidence of implant failure associated with bone loss, infection, and other complications. During your implant placement appointment, an antiseptic (povidone iodine) will be applied to the inside one of your two new dental implants, no antiseptic will be applied to your other dental implant (this is what would occur if you choose not to participate in this study), before covering both of them with a cover screw or healing abutment. You will return to the Madigan Oral \& Maxillofacial Surgery Clinic 3-6 months later when your implant hardware is removed a swab of the implants internal cavities will be collected. Your participation in this research will last up to 6 months and require one additional minute during both your implant placement and hardware removal appointments.

02

Conditions studied

  • Dental Implant

Keywords

  • Dental Implant
  • Povidone Iodine
  • Microbiome
03

In context

Lead sponsor

Madigan Army Medical Center is the lead sponsor of 26 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active Duty Military
  • 18-55 years old
  • Over 6 months remaining at local duty station (Joint Base Lewis McChord)
  • Will be undergoing surgery to receive at least two dental implants

Exclusion criteria

Exclusion Criteria:

  • Tobacco user
  • Taking medications affecting soft tissue or bone healing (e.g., IV bisphosphonates)
  • Metabolic disorder affecting soft tissue or bone healing (e.g., diabetes where AIC is above 7.0)
  • Active periodontal disease
  • Pregnant at time of enrollment (these surgeries are not typically performed on pregnant women)
  • Known or suspected allergy to OR previous adverse reaction to povidone iodine
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Other
    Case-Control Group

    The internal cavity of one dental implant will have a small volume of povidone iodine added to it before closure. The other dental implant will remain untreated.

    Drug: Povidone-Iodine

Interventions

  • All participants will receive this intervention in one implant and no intervention in a second implant.

06

What researchers measure

Primary outcomes

  1. Microbiome Diversity

    Inverse Simpson index calculated following 16S microbiome sequencing

    Time frame: From enrollment to hardware removal 3-6 months later

Secondary outcomes

  1. Implant Success Rate

    Time frame: From enrollment to hardware removal 3-6 months later

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Data may be shared if the appropriate regulatory approvals and agreements are in place.

Supporting information: Study protocol, Informed consent form

Time frame: For at least 3 years following manuscript publication

Access criteria: Investigators wishing to access the data should reach out to the study team. Data may be shared if the appropriate regulatory approvals and agreements are in place.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07899983
Lead sponsor
Madigan Army Medical Center
Responsible party
Sponsor
First posted
Oct 28, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Zachary Colburn, PhD
Contact
zachary.t.colburn.civ@health.mil
253-968-3455
Kevin Smith, DMD, FACS
Contact
kevin.d.smith2.mil@health.mil
253-968-0181
Kevin Smith, DMD, FACS
principal investigator · Madigan Army Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion